Literature DB >> 16978658

ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.

Zhen Xu1, Bai-Ren Wang, Xi Wang, Fang Kuang, Xiao-Li Duan, Xi-Ying Jiao, Gong Ju.   

Abstract

The enhanced production of nitric oxide (NO) via inducible nitric oxide synthase (iNOS) has been implicated in the pathogenesis of neuronal apoptosis after acute traumatic spinal cord injury (SCI). In the present study, to further characterize the pathways mediating the synthesis and release of NO, we examined activation of extracellular signal regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinases (p38 MAPK) in microglia/macrophages in the injured area of adult rats subjected to a complete transection at the T10 vertebrae level and assessed their role in NO production and survival of neurons by using immunohistochemistry, Western blot, RT-PCR and pharmacological interventions. Results showed activation of microglia/macrophages featured by morphological changes, as visualized immunohistochemically with the marker OX-42, in the areas adjacent to the lesion epicenter 1 h after surgery. Concomitantly, iNOS mRNA and its protein in the activated microglia/macrophages were also significantly upregulated at early hours after surgery. Their levels were maximal at 6 h, persisted for at least 24 h, and returned to basal level 72 h after SCI. Furthermore, phosphorylated ERK1/2 and p38 MAPK were activated as well in microglia/macrophages in injured area with a similar time course as iNOS. With administration of L-NAME, a NOS inhibitor, the number of apoptotic neurons was clearly decreased, as assessed with TUNEL method at 24 h after SCI. In parallel, loss of neurons induced by SCI, assessed with NeuN immunohistochemistry, was also diminished. Moreover, the effect of inhibition of phosphorylation ERK1/2 and p38 MAPK by corresponding inhibitors PD98059 and SB203580 administered before and after SCI was also investigated. Inhibition of p38 effectively reduced iNOS mRNA expression and rescued neurons from apoptosis and death in the area adjacent to the lesion epicenter; whereas the inhibition of ERK1/2 had a smaller effect on decrease of iNOS mRNA and no long-term protective effect on cell loss. These results indicate the ERK1/2 and p38 MAPK signaling pathway, especially the latter, play an important role in NO-mediated degeneration of neuron in the spinal cord following SCI. Strategies directed to blocking the initiation of this cascade prove to be beneficial for the treatment of acute SCI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978658     DOI: 10.1016/j.lfs.2006.06.023

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  44 in total

1.  Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?

Authors:  Satya Prakash Gupta; Suman Patel; Sharawan Yadav; Anand Kumar Singh; Seema Singh; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2010-05-09       Impact factor: 3.996

2.  Increased expression of a proline-rich Akt substrate (PRAS40) in human copper/zinc-superoxide dismutase transgenic rats protects motor neurons from death after spinal cord injury.

Authors:  Fengshan Yu; Purnima Narasimhan; Atsushi Saito; Jing Liu; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-25       Impact factor: 6.200

Review 3.  Regulatory mechanisms and therapeutic potential of microglial inhibitors in neuropathic pain and morphine tolerance.

Authors:  Er-Rong Du; Rong-Ping Fan; Li-Lou Rong; Zhen Xie; Chang-Shui Xu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

Review 4.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

Review 5.  The Biology of Regeneration Failure and Success After Spinal Cord Injury.

Authors:  Amanda Phuong Tran; Philippa Mary Warren; Jerry Silver
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

6.  Bone marrow mesenchymal stem cells combined with minocycline improve spinal cord injury in a rat model.

Authors:  Dayong Chen; Wei Zeng; Yunfeng Fu; Meng Gao; Guohua Lv
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Protective effect of verbascoside in activated C6 glioma cells: possible molecular mechanisms.

Authors:  Emanuela Esposito; Roberto Dal Toso; Giovanna Pressi; Placido Bramanti; Rosaria Meli; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-11       Impact factor: 3.000

8.  Protective effects of hyperbaric oxygen treatment against spinal cord injury in rats via toll-like receptor 2/nuclear factor-κB signaling.

Authors:  Jiewen Tan; Fang Zhang; Fang Liang; Yong Wang; Zhuo Li; Jing Yang; Xuehua Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 9.  Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.

Authors:  Gang Cheng; Rong-hua Kong; Lei-ming Zhang; Jian-ning Zhang
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

10.  Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury.

Authors:  Eric D Crown; Young Seob Gwak; Zaiming Ye; Kathia M Johnson; Claire E Hulsebosch
Journal:  Exp Neurol       Date:  2008-06-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.